Dr. Stanley Keith Frencher Jr., MD, MPH

Dr. Frencher practices at County of Los Angeles Auditor Controller in Los Angeles, California.

Dr. Frencher's NPI, 1124341086, was assigned on March 8, 2010. Dr. Frencher graduated from Albert Einstein College of Medicine in 2006. Dr. Frencher holds California license A109025.

Dr. Frencher's primary practice is County of Los Angeles Auditor Controller, at 12021 Wilmington Ave, Los Angeles, CA 90059 in Los Angeles County. The practice phone is (310) 668-4501.

Dr. Frencher's primary practice is County of Los Angeles Auditor Controller in Los Angeles, California. Dr. Frencher is also affiliated with Martin Luther King, Jr. Community Hospital. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Frencher to 1 more hospital, 2 group practices and clinics, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Frencher practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Frencher's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Frencher is board certified in urology by the American Board of Urology. Dr. Frencher is licensed in California.

Dmand AI lists enlarged prostate transurethral surgery (TURP) and kidney removal surgery among the conditions Dr. Frencher treats.

CMS data shows 117 Medicare services from Dr. Frencher across 4 procedure codes in 2024, for 97 Medicare patients. Medicare paid $4,964 for them. Every service was in an office.

CMS counts 97 Medicare patients who saw Dr. Frencher in 2024. The largest group is 65 to 74, with 60 patients. 73% of them have high blood pressure, and 65% have high cholesterol. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Frencher's median patient age at 63, with 27% women.

In 2024, Dr. Frencher wrote 247 Medicare Part D claims for 75 patients. 98% of them were for generic drugs. CMS names the drug for 195 of them, across 2 drugs with 11 or more claims each, at $3,240 in total drug cost. In 2023, CMS named 217 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Frencher for performance year 2024, reported through an alternative payment model (APM). Dr. Frencher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Frencher as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Frencher in 2025. Dr. Frencher's most frequent co-authors are Mehmet Asim Bilen, MD, Paul Denis Leger, MD and Jones Trevor Nauseef, MD, PhD.

CMS Open Payments shows 22 general payments to Dr. Frencher from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 71% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $1,188.

Dmand AI lists 9 awards for Dr. Frencher, most recently Top Doctor in 2014.

Dr. Frencher graduated from Albert Einstein College of Medicine in 2006.

Dr. Frencher is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.